{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:44:11Z","timestamp":1773297851277,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001108","name":"The Ophthalmic Research Institute of Australia","doi-asserted-by":"publisher","award":["ORIA\/Esme Anderson Grant"],"award-info":[{"award-number":["ORIA\/Esme Anderson Grant"]}],"id":[{"id":"10.13039\/501100001108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013805","name":"Retina Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013805","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1116360"],"award-info":[{"award-number":["APP1116360"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1142962"],"award-info":[{"award-number":["APP1142962"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006065","name":"Department of Health, Government of Western Australia","doi-asserted-by":"publisher","award":["New Independent Researcher Infrastructure Support Award"],"award-info":[{"award-number":["New Independent Researcher Infrastructure Support Award"]}],"id":[{"id":"10.13039\/501100006065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Foundation for the Prevention of Blindness"},{"name":"Global Ophthalmology Award Program Bayer"},{"name":"Miocevich Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10633-018-9665-7","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T04:38:53Z","timestamp":1542343133000},"page":"55-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G&gt;A mutation in ceroid lipofuscinosis neuronal 3 (CLN3)"],"prefix":"10.1007","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2809-9930","authenticated-orcid":false,"given":"Fred K.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Eintracht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukanya","family":"Arunachalam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3553-6457","authenticated-orcid":false,"given":"Jennifer A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enid","family":"Chelva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Mallon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Chih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terri","family":"McLaren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Lamey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"De Roach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5732-7387","authenticated-orcid":false,"given":"Samuel","family":"McLenachan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"issue":"6","key":"9665_CR1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/0092-8674(95)90274-0","volume":"82","author":"Consortium TIBD","year":"1995","unstructured":"Consortium TIBD (1995) Isolation of a novel gene underlying Batten disease, CLN3. Cell 82(6):949\u2013957","journal-title":"Cell"},{"issue":"2","key":"9665_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1086\/514846","volume":"61","author":"PB Munroe","year":"1997","unstructured":"Munroe PB, Mitchison HM, O\u2019Rawe AM, Anderson JW, Boustany RM, Lerner TJ, Taschner PE, de Vos N, Breuning MH, Gardiner RM, Mole SE (1997) Spectrum of mutations in the Batten disease gene, CLN3. Am J Hum Genet 61(2):310\u2013316","journal-title":"Am J Hum Genet"},{"issue":"5","key":"9665_CR3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ana.410420517","volume":"42","author":"I Jarvela","year":"1997","unstructured":"Jarvela I, Autti T, Lamminranta S, Aberg L, Raininko R, Santavuori P (1997) Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion). Ann Neurol 42(5):799\u2013802. \n                    https:\/\/doi.org\/10.1002\/ana.410420517","journal-title":"Ann Neurol"},{"issue":"2","key":"9665_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1212\/WNL.52.2.360","volume":"52","author":"L Lauronen","year":"1999","unstructured":"Lauronen L, Munroe PB, Jarvela I, Autti T, Mitchison HM, O\u2019Rawe AM, Gardiner RM, Mole SE, Puranen J, Hakkinen AM, Kirveskari E, Santavuori P (1999) Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis. Neurology 52(2):360\u2013365","journal-title":"Neurology"},{"issue":"1","key":"9665_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/ana.410430118","volume":"43","author":"KE Wisniewski","year":"1998","unstructured":"Wisniewski KE, Zhong N, Kaczmarski W, Kaczmarski A, Kida E, Brown WT, Schwarz KO, Lazzarini AM, Rubin AJ, Stenroos ES, Johnson WG, Wisniewski TM (1998) Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis. Ann Neurol 43(1):106\u2013110. \n                    https:\/\/doi.org\/10.1002\/ana.410430118","journal-title":"Ann Neurol"},{"issue":"3","key":"9665_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00439-013-1381-5","volume":"133","author":"F Wang","year":"2014","unstructured":"Wang F, Wang H, Tuan HF, Nguyen DH, Sun V, Keser V, Bowne SJ, Sullivan LS, Luo H, Zhao L, Wang X, Zaneveld JE, Salvo JS, Siddiqui S, Mao L, Wheaton DK, Birch DG, Branham KE, Heckenlively JR, Wen C, Flagg K, Ferreyra H, Pei J, Khan A, Ren H, Wang K, Lopez I, Qamar R, Zenteno JC, Ayala-Ramirez R, Buentello-Volante B, Fu Q, Simpson DA, Li Y, Sui R, Silvestri G, Daiger SP, Koenekoop RK, Zhang K, Chen R (2014) Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements. Hum Genet 133(3):331\u2013345. \n                    https:\/\/doi.org\/10.1007\/s00439-013-1381-5","journal-title":"Hum Genet"},{"issue":"7","key":"9665_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jamaophthalmol.2017.1401","volume":"135","author":"CA Ku","year":"2017","unstructured":"Ku CA, Hull S, Arno G, Vincent A, Carss K, Kayton R, Weeks D, Anderson GW, Geraets R, Parker C, Pearce DA, Michaelides M, MacLaren RE, Robson AG, Holder GE, Heon E, Raymond FL, Moore AT, Webster AR, Pennesi ME (2017) Detailed clinical phenotype and molecular genetic findings in CLN3-associated isolated retinal degeneration. JAMA Ophthalmol 135(7):749\u2013760. \n                    https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.1401","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"9665_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/13816810.2014.886271","volume":"36","author":"AV Drack","year":"2015","unstructured":"Drack AV, Mullins RF, Pfeifer WL, Augustine EF, Stasheff SF, Hong SD (2015) Immunosuppressive treatment for retinal degeneration in juvenile neuronal ceroid lipofuscinosis (juvenile batten disease). Ophthalmic Genet 36(4):359\u2013364. \n                    https:\/\/doi.org\/10.3109\/13816810.2014.886271","journal-title":"Ophthalmic Genet"},{"issue":"11","key":"9665_CR9","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1212\/01.WNL.0000145836.72059.3B","volume":"63","author":"DA Pearce","year":"2004","unstructured":"Pearce DA, Atkinson M, Tagle DA (2004) Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders. Neurology 63(11):2001\u20132005","journal-title":"Neurology"},{"issue":"1","key":"9665_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","volume":"130","author":"DL McCulloch","year":"2015","unstructured":"McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M (2015) ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol Adv Ophthalmol 130(1):1\u201312. \n                    https:\/\/doi.org\/10.1007\/s10633-014-9473-7","journal-title":"Doc Ophthalmol Adv Ophthalmol"},{"issue":"3","key":"9665_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10633-017-9587-9","volume":"134","author":"FK Chen","year":"2017","unstructured":"Chen FK, Chew AL, Zhang D, Chen SC, Chelva E, Chandrasekera E, Koay EMH, Forrester J, McLenachan S (2017) Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy. Doc Ophthalmol Adv Ophthalmol 134(3):227\u2013235. \n                    https:\/\/doi.org\/10.1007\/s10633-017-9587-9","journal-title":"Doc Ophthalmol Adv Ophthalmol"},{"issue":"5","key":"9665_CR12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/ceo.12020","volume":"41","author":"JN Roach De","year":"2013","unstructured":"De Roach JN, McLaren TL, Paterson RL, O\u2019Brien EC, Hoffmann L, Mackey DA, Hewitt AW, Lamey TM (2013) Establishment and evolution of the Australian inherited retinal disease register and DNA bank. Clin Exp Ophthalmol 41(5):476\u2013483. \n                    https:\/\/doi.org\/10.1111\/ceo.12020","journal-title":"Clin Exp Ophthalmol"},{"issue":"10","key":"9665_CR13","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1586\/14737159.2015.1081057","volume":"15","author":"JP Chiang","year":"2015","unstructured":"Chiang JP, Lamey T, McLaren T, Thompson JA, Montgomery H, De Roach J (2015) Progress and prospects of next-generation sequencing testing for inherited retinal dystrophy. Expert Rev Mol Diagn 15(10):1269\u20131275. \n                    https:\/\/doi.org\/10.1586\/14737159.2015.1081057","journal-title":"Expert Rev Mol Diagn"},{"issue":"6","key":"9665_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT Dunnen den","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Roux AF, Smith T, Antonarakis SE, Taschner PE (2016) HGVS recommendations for the description of sequence variants: 2016 update. Hum mutat 37(6):564\u2013569. \n                    https:\/\/doi.org\/10.1002\/humu.22981","journal-title":"Hum mutat"},{"issue":"6","key":"9665_CR15","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/mgg3.321","volume":"5","author":"JA Thompson","year":"2017","unstructured":"Thompson JA, De Roach JN, McLaren TL, Montgomery HE, Hoffmann LH, Campbell IR, Chen FK, Mackey DA, Lamey TM (2017) The genetic profile of Leber congenital amaurosis in an Australian cohort. Mol Genet Genomic Med 5(6):652\u2013667. \n                    https:\/\/doi.org\/10.1002\/mgg3.321","journal-title":"Mol Genet Genomic Med"},{"issue":"5","key":"9665_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for molecular pathology. Genet Med 17(5):405\u2013424. \n                    https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"9665_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2016.03.018","volume":"60","author":"G Aungaroon","year":"2016","unstructured":"Aungaroon G, Hallinan B, Jain P, Horn PS, Spaeth C, Arya R (2016) Correlation among genotype, phenotype, and histology in neuronal ceroid lipofuscinoses: an individual patient data meta-analysis. Pediatr Neurol 60:42\u201348.e44. \n                    https:\/\/doi.org\/10.1016\/j.pediatrneurol.2016.03.018","journal-title":"Pediatr Neurol"},{"issue":"1","key":"9665_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1399-0004.2009.01179.x","volume":"76","author":"A Sarpong","year":"2009","unstructured":"Sarpong A, Schottmann G, Ruther K, Stoltenburg G, Kohlschutter A, Hubner C, Schuelke M (2009) Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X). Clin Genet 76(1):38\u201345. \n                    https:\/\/doi.org\/10.1111\/j.1399-0004.2009.01179.x","journal-title":"Clin Genet"},{"issue":"1","key":"9665_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/nyas.12990","volume":"1371","author":"MM Ouseph","year":"2016","unstructured":"Ouseph MM, Kleinman ME, Wang QJ (2016) Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease). Ann N Y Acad Sci 1371(1):55\u201367. \n                    https:\/\/doi.org\/10.1111\/nyas.12990","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"9665_CR20","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/IAE.0b013e31819b0542","volume":"29","author":"DP Hainsworth","year":"2009","unstructured":"Hainsworth DP, Liu GT, Hamm CW, Katz ML (2009) Funduscopic and angiographic appearance in the neuronal ceroid lipofuscinoses. Retina 29(5):657\u2013668. \n                    https:\/\/doi.org\/10.1097\/IAE.0b013e31819b0542","journal-title":"Retina"},{"issue":"9","key":"9665_CR21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/bjo.2006.091637","volume":"90","author":"J Collins","year":"2006","unstructured":"Collins J, Holder GE, Herbert H, Adams GG (2006) Batten disease: features to facilitate early diagnosis. Br J Ophthalmol 90(9):1119\u20131124. \n                    https:\/\/doi.org\/10.1136\/bjo.2006.091637","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"9665_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1076\/1381-6810(200006)2121-8FT069","volume":"21","author":"LB Eksandh","year":"2000","unstructured":"Eksandh LB, Ponjavic VB, Munroe PB, Eiberg HE, Uvebrant PE, Ehinger BE, Mole SE, Andreasson S (2000) Full-field ERG in patients with Batten\/Spielmeyer-Vogt disease caused by mutations in the CLN3 gene. Ophthalmic Genet 21(2):69\u201377","journal-title":"Ophthalmic Genet"},{"issue":"6","key":"9665_CR23","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1136\/bjophthalmol-2015-307320","volume":"100","author":"S Dulz","year":"2016","unstructured":"Dulz S, Wagenfeld L, Nickel M, Richard G, Schwartz R, Bartsch U, Kohlschutter A, Schulz A (2016) Novel morphological macular findings in juvenile CLN3 disease. Br J Ophthalmol 100(6):824\u2013828. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307320","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"9665_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/icb.0000000000000200","volume":"10","author":"MS Hansen","year":"2016","unstructured":"Hansen MS, Hove MN, Jensen H, Larsen M (2016) Optical coherence tomography in juvenile neuronal ceroid lipofuscinosis. Retin Cases Brief Rep 10(2):137\u2013139. \n                    https:\/\/doi.org\/10.1097\/icb.0000000000000200","journal-title":"Retin Cases Brief Rep"},{"issue":"3","key":"9665_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/13816810.2016.1210651","volume":"38","author":"MN Preising","year":"2017","unstructured":"Preising MN, Abura M, J\u00e4ger M, Wassill K-H, Lorenz B (2017) Ocular morphology and function in juvenile neuronal ceroid lipofuscinosis (CLN3) in the first decade of life. Ophthalmic Genet 38(3):252\u2013259","journal-title":"Ophthalmic Genet"},{"issue":"1","key":"9665_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.nbd.2007.08.007","volume":"29","author":"JA Castaneda","year":"2008","unstructured":"Castaneda JA, Pearce DA (2008) Identification of alpha-fetoprotein as an autoantigen in juvenile Batten disease. Neurobiol Dis 29(1):92\u2013102. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2007.08.007","journal-title":"Neurobiol Dis"},{"issue":"12","key":"9665_CR27","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/hmg\/11.12.1421","volume":"11","author":"S Chattopadhyay","year":"2002","unstructured":"Chattopadhyay S, Ito M, Cooper JD, Brooks AI, Curran TM, Powers JM, Pearce DA (2002) An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum Mol Genet 11(12):1421\u20131431","journal-title":"Hum Mol Genet"},{"issue":"5","key":"9665_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2990.2006.00738.x","volume":"32","author":"MJ Lim","year":"2006","unstructured":"Lim MJ, Beake J, Bible E, Curran TM, Ramirez-Montealegre D, Pearce DA, Cooper JD (2006) Distinct patterns of serum immunoreactivity as evidence for multiple brain-directed autoantibodies in juvenile neuronal ceroid lipofuscinosis. Neuropathol Appl Neurobiol 32(5):469\u2013482. \n                    https:\/\/doi.org\/10.1111\/j.1365-2990.2006.00738.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"9665_CR29","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/01.wnl.0000151973.08426.7e","volume":"64","author":"D Ramirez-Montealegre","year":"2005","unstructured":"Ramirez-Montealegre D, Chattopadhyay S, Curran TM, Wasserfall C, Pritchard L, Schatz D, Petitto J, Hopkins D, She JX, Rothberg PG, Atkinson M, Pearce DA (2005) Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Neurology 64(4):743\u2013745. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000151973.08426.7e","journal-title":"Neurology"},{"issue":"1\u20132","key":"9665_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jneuroim.2010.08.024","volume":"230","author":"SS Seehafer","year":"2011","unstructured":"Seehafer SS, Ramirez-Montealegre D, Wong AM, Chan CH, Castaneda J, Horak M, Ahmadi SM, Lim MJ, Cooper JD, Pearce DA (2011) Immunosuppression alters disease severity in juvenile Batten disease mice. J Neuroimmunol 230(1\u20132):169\u2013172. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2010.08.024","journal-title":"J Neuroimmunol"},{"issue":"8","key":"9665_CR31","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.ymthe.2017.04.021","volume":"25","author":"J Groh","year":"2017","unstructured":"Groh J, Berve K, Martini R (2017) Fingolimod and teriflunomide attenuate neurodegeneration in mouse models of neuronal ceroid lipofuscinosis. Mol Ther 25(8):1889\u20131899. \n                    https:\/\/doi.org\/10.1016\/j.ymthe.2017.04.021","journal-title":"Mol Ther"},{"key":"9665_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1471-2415-14-154","volume":"14","author":"G Adamus","year":"2014","unstructured":"Adamus G, Chew EY, Ferris FL, Klein ML (2014) Prevalence of anti-retinal autoantibodies in different stages of age-related macular degeneration. BMC Ophthalmol 14:154. \n                    https:\/\/doi.org\/10.1186\/1471-2415-14-154","journal-title":"BMC Ophthalmol"},{"key":"9665_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2415-4-5","volume":"4","author":"G Adamus","year":"2004","unstructured":"Adamus G, Ren G, Weleber RG (2004) Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol 4:5. \n                    https:\/\/doi.org\/10.1186\/1471-2415-4-5","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"9665_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0002-9394(98)00446-2","volume":"127","author":"JR Heckenlively","year":"1999","unstructured":"Heckenlively JR, Jordan BL, Aptsiauri N (1999) Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 127(5):565\u2013573","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"9665_CR35","doi-asserted-by":"publisher","first-page":"e0145323","DOI":"10.1371\/journal.pone.0145323","volume":"10","author":"A Iannaccone","year":"2015","unstructured":"Iannaccone A, Giorgianni F, New DD, Hollingsworth TJ, Umfress A, Alhatem AH, Neeli I, Lenchik NI, Jennings BJ, Calzada JI, Satterfield S, Mathews D, Diaz RI, Harris T, Johnson KC, Charles S, Kritchevsky SB, Gerling IC, Beranova-Giorgianni S, Radic MZ (2015) Circulating autoantibodies in age-related macular degeneration recognize human macular tissue antigens implicated in autophagy, immunomodulation, and protection from oxidative stress and apoptosis. PLoS ONE 10(12):e0145323. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0145323","journal-title":"PLoS ONE"},{"issue":"8","key":"9665_CR36","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1167\/iovs.13-12050","volume":"54","author":"L Zhu","year":"2013","unstructured":"Zhu L, Shen W, Zhu M, Coorey NJ, Nguyen AP, Barthelmes D, Gillies MC (2013) Anti-retinal antibodies in patients with macular telangiectasia type 2. Invest Ophthalmol Vis Sci 54(8):5675\u20135683. \n                    https:\/\/doi.org\/10.1167\/iovs.13-12050","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9665_CR37","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3389\/fimmu.2018.00765","volume":"9","author":"G Adamus","year":"2018","unstructured":"Adamus G (2018) Are anti-retinal autoantibodies a cause or a consequence of retinal degeneration in autoimmune retinopathies? Front Immunol 9:765. \n                    https:\/\/doi.org\/10.3389\/fimmu.2018.00765","journal-title":"Front Immunol"},{"issue":"11","key":"9665_CR38","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1001\/archopht.118.11.1525","volume":"118","author":"JR Heckenlively","year":"2000","unstructured":"Heckenlively JR, Fawzi AA, Oversier J, Jordan BL, Aptsiauri N (2000) Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration. Arch Ophthalmol 118(11):1525\u20131533","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"9665_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13023-017-0680-7","volume":"12","author":"K Boudreault","year":"2017","unstructured":"Boudreault K, Justus S, Sengillo JD, Schuerch K, Lee W, Cabral T, Tsang SH (2017) Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy. Orphanet J Rare Dis 12(1):129. \n                    https:\/\/doi.org\/10.1186\/s13023-017-0680-7","journal-title":"Orphanet J Rare Dis"},{"key":"9665_CR40","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ajo.2017.04.019","volume":"180","author":"S Davoudi","year":"2017","unstructured":"Davoudi S, Ebrahimiadib N, Yasa C, Sevgi DD, Roohipoor R, Papavasilieou E, Comander J, Sobrin L (2017) Outcomes in autoimmune retinopathy patients treated with rituximab. Am J Ophthalmol 180:124\u2013132. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2017.04.019","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"9665_CR41","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/j.jcjo.2015.08.009","volume":"50","author":"A Fox","year":"2015","unstructured":"Fox A, Jeffrey B, Hasni S, Nussenblatt R, Sen HN (2015) Rituximab treatment for nonparaneoplastic autoimmune retinopathy. Can J Ophthalmol 50(6):e101\u2013e104. \n                    https:\/\/doi.org\/10.1016\/j.jcjo.2015.08.009","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"9665_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2217\/clp.11.70","volume":"7","author":"SL Cotman","year":"2012","unstructured":"Cotman SL, Staropoli JF (2012) The juvenile Batten disease protein, CLN3, and its role in regulating anterograde and retrograde post-Golgi trafficking. Clin Lipidol 7(1):79\u201391. \n                    https:\/\/doi.org\/10.2217\/clp.11.70","journal-title":"Clin Lipidol"},{"issue":"3","key":"9665_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1006\/mgme.2000.3006","volume":"70","author":"AA Golabek","year":"2000","unstructured":"Golabek AA, Kida E, Walus M, Kaczmarski W, Michalewski M, Wisniewski KE (2000) CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer\u2019s amyloid-beta protein precursor and cathepsin D in human cells. Mol Genet Metab 70(3):203\u2013213. \n                    https:\/\/doi.org\/10.1006\/mgme.2000.3006","journal-title":"Mol Genet Metab"},{"issue":"8","key":"9665_CR44","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1093\/hmg\/ddt596","volume":"23","author":"X Lojewski","year":"2014","unstructured":"Lojewski X, Staropoli JF, Biswas-Legrand S, Simas AM, Haliw L, Selig MK, Coppel SH, Goss KA, Petcherski A, Chandrachud U, Sheridan SD, Lucente D, Sims KB, Gusella JF, Sondhi D, Crystal RG, Reinhardt P, Sterneckert J, Scholer H, Haggarty SJ, Storch A, Hermann A, Cotman SL (2014) Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway. Hum Mol Genet 23(8):2005\u20132022. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddt596","journal-title":"Hum Mol Genet"},{"issue":"3","key":"9665_CR45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ymgme.2008.01.001","volume":"93","author":"D Rakheja","year":"2008","unstructured":"Rakheja D, Narayan SB, Bennett MJ (2008) The function of CLN3P, the Batten disease protein. Mol Genet Metab 93(3):269\u2013274","journal-title":"Mol Genet Metab"},{"issue":"4","key":"9665_CR46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s1059-1311(03)00163-8","volume":"13","author":"S Sinha","year":"2004","unstructured":"Sinha S, Satishchandra P, Santosh V, Gayatri N, Shankar SK (2004) Neuronal ceroid lipofuscinosis: a clinicopathological study. Seizure 13(4):235\u2013240. \n                    https:\/\/doi.org\/10.1016\/s1059-1311(03)00163-8","journal-title":"Seizure"},{"key":"9665_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/brain\/100.1.137","volume":"100","author":"S Carpenter","year":"1977","unstructured":"Carpenter S, Karpati G, Andermann F, Jacob J, Andermann E (1977) The ultrastructural characteristics of the abnormal cytosomes in Batten-Kufs\u2019 disease. Brain J Neurol 100:137\u2013156","journal-title":"Brain J Neurol"},{"issue":"D1","key":"9665_CR48","doi-asserted-by":"publisher","first-page":"D762","DOI":"10.1093\/nar\/gkx1020","volume":"46","author":"J Casper","year":"2018","unstructured":"Casper J, Zweig AS, Villarreal C, Tyner C, Speir ML, Rosenbloom KR, Raney BJ, Lee CM, Lee BT, Karolchik D, Hinrichs AS, Haeussler M, Guruvadoo L, Navarro Gonzalez J, Gibson D, Fiddes IT, Eisenhart C, Diekhans M, Clawson H, Barber GP, Armstrong J, Haussler D, Kuhn RM, Kent WJ (2018) The UCSC genome browser database: 2018 update. Nucleic Acids Res 46(D1):D762\u2013d769. \n                    https:\/\/doi.org\/10.1093\/nar\/gkx1020","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"9665_CR49","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/hmg\/8.6.1091","volume":"8","author":"I Jarvela","year":"1999","unstructured":"Jarvela I, Lehtovirta M, Tikkanen R, Kyttala A, Jalanko A (1999) Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL). Hum Mol Genet 8(6):1091\u20131098","journal-title":"Hum Mol Genet"},{"key":"9665_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2015.05.011","author":"SE Mole","year":"2015","unstructured":"Mole SE, Cotman SL (2015) Genetics of the neuronal ceroid lipofuscinoses (Batten disease). Biochimica et biophysica acta. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2015.05.011","journal-title":"Biochimica et biophysica acta"},{"issue":"3","key":"9665_CR51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<199::AID-HUMU3>3.0.CO;2-A","volume":"14","author":"SE Mole","year":"1999","unstructured":"Mole SE, Mitchison HM, Munroe PB (1999) Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5. Hum Mutat 14(3):199\u2013215. \n                    https:\/\/doi.org\/10.1002\/(SICI)1098-1004(1999)14:3%3c199:AID-HUMU3%3e3.0.CO;2-A","journal-title":"Hum Mutat"},{"issue":"2","key":"9665_CR52","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/hmg\/ddm306","volume":"17","author":"C Kitzmuller","year":"2008","unstructured":"Kitzmuller C, Haines RL, Codlin S, Cutler DF, Mole SE (2008) A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis. Hum Mol Genet 17(2):303\u2013312. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddm306","journal-title":"Hum Mol Genet"},{"issue":"21","key":"9665_CR53","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1093\/hmg\/ddn228","volume":"17","author":"CH Chan","year":"2008","unstructured":"Chan CH, Mitchison HM, Pearce DA (2008) Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models. Hum Mol Genet 17(21):3332\u20133339. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddn228","journal-title":"Hum Mol Genet"},{"issue":"13","key":"9665_CR54","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1093\/hmg\/ddt120","volume":"22","author":"JN Miller","year":"2013","unstructured":"Miller JN, Chan CH, Pearce DA (2013) The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis. Hum Mol Genet 22(13):2723\u20132734. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddt120","journal-title":"Hum Mol Genet"},{"issue":"8","key":"9665_CR55","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00417-014-2814-0","volume":"253","author":"R Bergholz","year":"2015","unstructured":"Bergholz R, Kohlschutter A, Schulz A, Hubert W, Ruther K (2015) Phenotyping heterozygous carriers of juvenile neuronal ceroid lipofuscinosis with CLN3 mutations. Graefe\u2019s Arch Clin Exp Ophthalmol 253(8):1245\u20131250. \n                    https:\/\/doi.org\/10.1007\/s00417-014-2814-0","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"9665_CR56","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/1471-2164-14-486","volume":"14","author":"MH Farkas","year":"2013","unstructured":"Farkas MH, Grant GR, White JA, Sousa ME, Consugar MB, Pierce EA (2013) Transcriptome analyses of the human retina identify unprecedented transcript diversity and 3.5\u00a0Mb of novel transcribed sequence via significant alternative splicing and novel genes. BMC Genom 14:486. \n                    https:\/\/doi.org\/10.1186\/1471-2164-14-486","journal-title":"BMC Genom"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10633-018-9665-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-018-9665-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-018-9665-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T19:40:18Z","timestamp":1573846818000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10633-018-9665-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,16]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["9665"],"URL":"https:\/\/doi.org\/10.1007\/s10633-018-9665-7","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,16]]},"assertion":[{"value":"24 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Data generated during the course of the current study are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"No animals were used in this study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}}]}}